RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $407 from $402 and keeps a Sector Perform rating on the shares.

Pre-earnings options volume in Vertex is normal with calls leading puts 7:4. Implied volatility suggests the market is anticipating a move near 4.1%, or $19.25, after results are released.

Bruker Corporation announced the launch of the VERTEX NEO Platform with its first product, the VERTEX NEO R. This release marks a continuation of providing high-end Fourier-Transform Infrared (FTIR) ...

HONG KONG — What a difference a few months makes. The United States and its longtime allies Japan and South Korea have been strengthening ties in recent years, both individually and as a three ...

The VERTEX 80 and the VERTEX 80v vacuum FT-IR spectrometers from Bruker are based on the actively aligned UltraScan ™ interferometer, which provides PEAK spectral resolution. The precise linear ...

Several gold stocks are in bases with earnings due. Two made new highs on Monday amid safe-haven demand on Trump tariff fears ...

Vertex has doubled down on cell-based therapies ... setting up one of the largest private equity buyouts in Japan's health sector.

Talk about wealth-generating powerhouses — a handful of S&P 500 companies now pull in at least $10,000 a second in revenue.

Airport operations were minimally impacted because the incident occurred on a taxi lane. A Japan Airlines plane, during tarmac operations, collided with a Delta Airlines aircraft at Seattle-Tacoma ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

ANALYSIS — Japanese Prime Minister Shigeru Ishiba seemed to know just what to say, and not say, during a joint news conference Friday with President Donald Trump. Asked whether his government ...

R.Park, A.R.Allen, C.B.Brown, R.Chahayed, O.Fedi, P.M.Lawrence II, Bruno Mars, T.M.Thomas, H.R.Walter, M.D.Chapman, N.Chinn Bruno Mars, Cirkut, O.Fedi, R.Chahayed ...